Kim Tan

Chairman

SpringHill Management

Dr. Kim Tan is Chairman of SpringHill Management, a private fund management company specializing in biotech and social venture capital investments. SpringHill BioVentures invested in early-stage biotech companies in Asia, India, UK, and the US. Kim has been a pioneer of social impact investing for over 20 years and is a partner of several social impact funds, including Inqo Investments (South Africa), Novastar Ventures (Kenya), and Garden Impact Investment (Singapore). He is also an advisor to Johnson & Johnson Impact Ventures, the co-founder of the Transformational Business Network, and a trustee of the John Templeton Foundation, Templeton Religion Trust, and the Centre for Enterprise, Markets & Ethics (Oxford).

LinkedIn

Image Coming Soon

i enjoy connecting with praxis fellows ON...